Kewaunee Scientific Corporation (KEQU)
NASDAQ: KEQU · Real-Time Price · USD
33.40
-0.04 (-0.12%)
Nov 2, 2026, 4:00 PM EST - Market closed
Kewaunee Scientific Financials Overview
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Revenue Revenue Growth | 277.22 | 282 | 240.47 | 203.76 | 219.49 | 168.87 |
Revenue Growth | 5.33% | 17.27% | 18.02% | -7.17% | 29.98% | 14.51% |
Gross Profit Gross Profit Growth | 79.15 | 80.44 | 68.86 | 52.05 | 35.59 | 24.22 |
Operating Income Operating Income Growth | 15.06 | 16.72 | 17.76 | 18.12 | 5.29 | -2.23 |
Net Income Net Income Growth | 8.23 | 9.62 | 11.41 | 18.75 | 0.74 | -6.13 |
Earnings Per Share EPS Growth | 2.76 | 3.22 | 3.83 | 6.38 | 0.25 | -2.20 |
EPS Growth | -33.04% | -15.93% | -39.97% | 2452.00% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
International International Growth | 69.82 | 70.31 | 64.54 | 70.58 | 72.78 | 42.02 |
Lab Products Group Lab Products Group Growth | 214.12 | 216.83 | 180.02 | 137.87 | 146.72 | 126.85 |
Corporate/Eliminations Corporate/Eliminations Growth | -6.73 | -5.15 | -4.09 | -4.7 | - | - |
Total Total Growth | 277.22 | 282 | 240.47 | 203.76 | 219.49 | 168.87 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Investments Cash & Investments Growth | 8.25 | 9.95 | 14.94 | 23.27 | 8.08 | 4.43 |
Total Debt Total Debt Growth | 55.47 | 56.82 | 77.58 | 39.14 | 41.7 | 38.79 |
Net Cash (Debt) Net Cash Growth | -47.23 | -46.87 | -62.63 | -15.87 | -33.62 | -34.36 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.89 | -15.71 | -21.02 | -5.40 | -11.58 | -12.33 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 14.82 | 18.63 | 14.78 | 19.56 | -3.79 | -7.89 |
Capital Expenditures CapEx Growth | -3.94 | -3.94 | -2.17 | -4.37 | -4.15 | -1.91 |
Free Cash Flow Free Cash Flow Growth | 10.88 | 14.7 | 12.62 | 15.19 | -7.94 | -9.79 |
Free Cash Flow Growth | -41.85% | 16.48% | -16.94% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Gross Margin | 28.55% | 28.52% | 28.63% | 25.55% | 16.21% | 14.34% |
Operating Margin | 5.43% | 5.93% | 7.38% | 8.89% | 2.41% | -1.32% |
Pretax Margin | 4.46% | 4.87% | 6.15% | 6.44% | 2.05% | -1.47% |
Profit Margin | 2.97% | 3.41% | 4.74% | 9.20% | 0.34% | -3.63% |
FCF Margin | 3.92% | 5.21% | 5.25% | 7.46% | -3.62% | -5.80% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
PE Ratio | 12.08 | 11.03 | 7.93 | 5.47 | 62.32 | - |
Forward PE | - | 7.54 | 7.54 | 7.54 | 7.54 | 7.54 |
P/FCF Ratio | 8.89 | 7.22 | 7.17 | 6.76 | - | - |
PS Ratio | 0.35 | 0.38 | 0.38 | 0.50 | 0.21 | 0.24 |